|
Iamna - õhukese polümeerikattega tablett (0,06mg +0,015mg)
|
gestodeen +etünüülöstradiool |
G03AA10 |
Sandoz Pharmaceuticals d.d. |
|
Iasibon
|
ibandroonhape |
M05BA06 |
Pharmathen S.A. |
|
Iasocholine 1 gbqml, süstelahus - süstelahus (1gbq 1ml)
|
fluorometüülkoliin (18F) |
V09IX07 |
IASON GmbH |
|
Ibandronic acid accord
|
ibandroonhape |
M05BA06 |
Accord Healthcare S.L.U. |
|
Ibandronic acid Actavis
|
– |
– |
– |
|
Ibandronic acid actavis 150mg - õhukese polümeerikattega tablett (150mg)
|
ibandroonhape |
M05BA06 |
Actavis Group PTC ehf |
|
Ibandronic acid actavis 50mg - õhukese polümeerikattega tablett (50mg)
|
ibandroonhape |
M05BA06 |
Actavis Group PTC ehf |
|
Ibandronic acid Liconsa
|
– |
– |
– |
|
Ibandronic Acid Portfarma
|
– |
– |
– |
|
Ibandronic acid ratiopharm - infusioonilahuse kontsentraat (6mg 6ml)
|
ibandroonhape |
M05BA06 |
ratiopharm GmbH |
|
Ibandronic acid ratiopharm - süstelahus süstlis (3mg 3ml)
|
ibandroonhape |
M05BA06 |
ratiopharm GmbH |
|
Ibandronic Acid Sandoz
|
ibandronic acid |
M05BA06 |
Sandoz Pharmaceuticals GmbH |
|
Ibandronic acid synthon 150mg - õhukese polümeerikattega tablett (150mg)
|
ibandroonhape |
M05BA06 |
Synthon BV |
|
Ibandronic acid synthon 50mg - õhukese polümeerikattega tablett (50mg)
|
ibandroonhape |
M05BA06 |
Synthon BV |
|
Ibandronic Acid Teva
|
ibandroonhape |
M05BA06 |
Teva Pharma B.V. |
|
Iberogast - suukaudne vedelik
|
taimsed preparaadid |
T01RS01 |
UAB Bayer |
|
Iberoherb - suukaudsed tilgad, vedelik
|
mõru ibeeris +kummeliõis +köömnevili +melissileht +piparmündileht +lagritsajuur |
A03AX84 |
Bayer UAB |
|
Ibravix - õhukese polümeerikattega tablett (500mg +200mg)
|
paratsetamool +ibuprofeen |
N02BE70 |
Sandoz Pharmaceuticals d.d. |
|
Ibudolor - õhukese polümeerikattega tablett (200mg)
|
ibuprofeen |
M01AE01 |
Stada Arzneimittel AG |
|
Ibuflux 400 mg - tabl 400mg n20; n10; n30
|
Ibuprofen |
M01AE01 |
AS Grindeks |
|
Ibuliq - pehmekapsel (400mg)
|
ibuprofeen |
M01AE01 |
NVT UAB |
|
Ibumax - õhukese polümeerikattega tablett (200mg)
|
ibuprofeen |
M01AE01 |
VITABALANS OY |
|
Ibumax - õhukese polümeerikattega tablett (400mg)
|
ibuprofeen |
M01AE01 |
VITABALANS OY |
|
Ibumax - õhukese polümeerikattega tablett (600mg)
|
ibuprofeen |
M01AE01 |
VITABALANS OY |
|
Ibumed
|
ibuprofeen |
M01AE01 |
Medochemie Limited |
|
Ibumetin - geel (5%)
|
ibuprofeen |
M02AA13 |
Takeda Pharma AS |
|
Ibumetin - geel 5% 50g
|
Ibuprofen |
M02AA13 |
Takeda Pharma AS |
|
Ibumetin - õhukese polümeerikattega tablett (200mg)
|
ibuprofeen |
M01AE01 |
Takeda Pharma AS |
|
Ibumetin - õhukese polümeerikattega tablett (400mg)
|
ibuprofeen |
M01AE01 |
Takeda Pharma AS |
|
Ibumetin - õhukese polümeerikattega tablett (600mg)
|
ibuprofeen |
M01AE01 |
Takeda Pharma AS |
|
Ibumetin - suukaudne susp 20mg / 1ml 100ml n1
|
Ibuprofen |
M01AE01 |
Takeda Pharma AS |
|
Ibumetin - tabl 200mg n100
|
Ibuprofen |
M01AE01 |
Takeda Pharma AS |
|
Ibumetin - tabl 600mg n100
|
Ibuprofen |
M01AE01 |
Takeda Pharma AS |
|
Ibumetin 200
|
– |
– |
– |
|
Ibumetin 400
|
– |
– |
– |
|
Ibumetin 600
|
– |
– |
– |
|
Ibumetin express - pehmekapsel (400mg)
|
ibuprofeen |
M01AE01 |
Orifarm Healthcare A/S |
|
Ibuparol - õhukese polümeerikattega tablett (500mg +150mg)
|
paratsetamool +ibuprofeen |
N02BE73 |
Amicus Pharma Kft. |
|
Ibuprofen accord - õhukese polümeerikattega tablett (200mg)
|
ibuprofeen |
M01AE01 |
Accord Healthcare Limited |
|
Ibuprofen accord - õhukese polümeerikattega tablett (400mg)
|
ibuprofeen |
M01AE01 |
Accord Healthcare Limited |
|
Ibuprofen accord - õhukese polümeerikattega tablett (600mg)
|
ibuprofeen |
M01AE01 |
Accord Healthcare Limited |
|
Ibuprofen actavis - õhukese polümeerikattega tablett (400mg)
|
ibuprofeen |
M01AE01 |
Actavis Group PTC ehf |
|
Ibuprofen actavis - õhukese polümeerikattega tablett (600mg)
|
ibuprofeen |
M01AE01 |
Actavis Group PTC ehf |
|
Ibuprofen actavis - õhukese polümeerikattega tablett (800mg)
|
ibuprofeen |
M01AE01 |
Actavis Group PTC ehf |
|
Ibuprofen actavis - suukaudne suspensioon kotikeses (100mg)
|
ibuprofeen |
M01AE01 |
Actavis Group PTC ehf |
|
Ibuprofen actavis - suukaudne suspensioon kotikeses (150mg)
|
ibuprofeen |
M01AE01 |
Actavis Group PTC ehf |
|
Ibuprofen actavis - suukaudne suspensioon kotikeses (200mg)
|
ibuprofeen |
M01AE01 |
Actavis Group PTC ehf |
|
Ibuprofen actavis - suukaudne suspensioon kotikeses (300mg)
|
ibuprofeen |
M01AE01 |
Actavis Group PTC ehf |
|
Ibuprofen actavis - suukaudne suspensioon kotikeses (50mg)
|
ibuprofeen |
M01AE01 |
Actavis Group PTC ehf |
|
Ibuprofen b. braun - infusioonilahus (4mg 1ml)
|
ibuprofeen |
M01AE01 |
B. Braun Melsungen AG |
|
Ibuprofen b. braun - infusioonilahus (6mg 1ml)
|
ibuprofeen |
M01AE01 |
B. Braun Melsungen AG |
|
Ibuprofen catalent
|
ibuprofeen |
M01AE01 |
Catalent Germany Eberbach GmbH |
|
Ibuprofen gen.orph - süstelahus (5mg 1ml)
|
ibuprofeen |
C01EB16 |
Gen.Orph |
|
Ibuprofen lannacher - õhukese polümeerikattega tablett (400mg)
|
ibuprofeen |
M01AE01 |
G.L. Pharma GmbH |
|
Ibuprofen lannacher - õhukese polümeerikattega tablett (600mg)
|
ibuprofeen |
M01AE01 |
G.L. Pharma GmbH |
|
Ibuprofen nutra essential
|
ibuprofeen |
M01AE01 |
Farmalider S.A. |
|
Ibuprofen pharmaswiss - suukaudne suspensioon (20mg 1ml)
|
ibuprofeen |
M01AE01 |
PharmaSwiss Ceska republika s.r.o |
|
Ibuprofen stada - pehmekapsel (400mg)
|
ibuprofeen |
M01AE01 |
Stada Arzneimittel AG |
|
Ibuprofen stada arzneimittel - õhukese polümeerikattega tablett (600mg)
|
ibuprofeen |
M01AE01 |
Stada Arzneimittel AG |
|
Ibuprofen stada arzneimittel ag
|
ibuprofeen |
M01AE01 |
Stada Arzneimittel AG |
|
Ibuprofen zentiva - õhukese polümeerikattega tablett (400mg)
|
ibuprofeen |
M01AE01 |
Zentiva k.s. |
|
Ibuprofen-grindeks - õhukese polümeerikattega tablett (200mg)
|
ibuprofeen |
M01AE01 |
Grindeks AS |
|
Ibuprofen-grindeks - õhukese polümeerikattega tablett (400mg)
|
ibuprofeen |
M01AE01 |
Grindeks AS |
|
Ibuprofen-grindeks - tabl 200mg n20; n50
|
Ibuprofen |
M01AE01 |
AS Grindeks |
|
Ibuprofen-ratiopharm 200 mg
|
– |
– |
– |
|
Ibuprofen-ratiopharm 400 mg - õhukese polümeerikattega tablett (400mg)
|
ibuprofeen |
M01AE01 |
ratiopharm GmbH |
|
Ibuprofencaffeine teva - õhukese polümeerikattega tablett (400mg +100mg)
|
ibuprofeen +kofeiin |
M01AE84 |
Teva B.V. |
|
Ibuprofenum us pharmacia
|
ibuprofeen |
M01AE01 |
Us Pharmacia Sp. z o.o. |
|
Ibustar - õhukese polümeerikattega tablett (400mg)
|
ibuprofeen |
M01AE01 |
Berlin-Chemie AG (Menarini Group) |
|
Ibustar - suukaudne suspensioon (100mg 5ml)
|
ibuprofeen |
M01AE01 |
Berlin-Chemie AG (Menarini Group) |
|
Ibustar forte - suukaudne suspensioon (40mg 1ml)
|
ibuprofeen |
M01AE01 |
Berlin-Chemie AG (Menarini Group) |
|
Ibutop - geel (5%)
|
ibuprofeen |
M02AA13 |
DOLORGIET GmbH & Co. KG |
|
Icalziss - infusioonilahus (340mmol 1l)
|
kaltsiumkloriid |
B05XA07 |
Vantive Belgium |
|
Icandra
|
metformiin +vildagliptiin |
A10BD08 |
Novartis Europharm Limited |
|
Icandra (previously Vildagliptin / metformin hydrochloride Novartis)
|
vildagliptin / metformin hydrochloride |
A10BD08 |
Novartis Europharm Ltd. |
|
Icatibant accord - süstelahus süstlis (30mg 3ml)
|
ikatibant |
B06AC02 |
Accord Healthcare S.L.U. |
|
Icatibant auxilia - süstelahus süstlis (30mg 3ml)
|
ikatibant |
B06AC02 |
Auxilia Pharma OÜ |
|
Iclusig
|
ponatiniib |
L01XE24 |
Incyte Biosciences Distribution B.V. |
|
Ictastan - õhukese polümeerikattega tablett (245mg +200mg)
|
tenofoviirdisoproksiil +emtritsitabiin |
J05AR03 |
Actavis Group PTC ehf |
|
Idacio
|
adalimumab |
L04AB04 |
Fresenius Kabi Deutschland GmbH |
|
Idanuz - süstelahus süstlis (30mg)
|
ikatibant |
B06AC02 |
Norameda UAB |
|
Idarubicin accord - süstelahus (10mg 10ml)
|
idarubitsiin |
L01DB06 |
Accord Healthcare Limited |
|
Idarubicin accord - süstelahus (20mg 20ml)
|
idarubitsiin |
L01DB06 |
Accord Healthcare Limited |
|
Idarubicin accord - süstelahus (5mg 5ml)
|
idarubitsiin |
L01DB06 |
Accord Healthcare Limited |
|
Idefirix - infusioonilahuse kontsentraadi pulber (11mg)
|
imlifidaas |
L04AA41 |
Hansa Biopharma AB |
|
Idelvion
|
IX hüübimisfaktor |
B02BD04 |
CSL Behring GmbH |
|
Ideos - närimistablett (500mg +400rü)
|
kaltsium +kolekaltsiferool |
A12AX80 |
LABORATOIRE INNOTECH INTERNATIONAL |
|
IDflu
|
A/California/7/2009 (H1N1)pdm09-derived strain used (NYMC X-179A)
A/Victoria/361/2011 (H3N2)-like strain used (NYMC X-223A) derived from A/Texas/50/2012
B/Massachusetts/02/2012 |
J07BB02 |
Sanofi Pasteur S.A. |
|
Ifenin - õhukese polümeerikattega tablett (200mg)
|
ibuprofeen |
M01AE01 |
Actavis Group PTC ehf |
|
Ifenin - õhukese polümeerikattega tablett (400mg)
|
ibuprofeen |
M01AE01 |
Actavis Group PTC ehf |
|
Ifirmacombi
|
irbesartan / hydrochlorothiazide |
C09DA83 |
Krka, d.d., Novo mesto |
|
Ifirmasta
|
irbesartaan |
C09CA04 |
KRKA tovarna zdravil d.d. Novo mesto |
|
Ifirmasta (previously Irbesartan Krka)
|
irbesartan hydrochloride |
C09CA04 |
Krka, d.d., Novo mesto |
|
Igzelymas - kõvakapsel (90mg +50mg)
|
tikagreloor +atsetüülsalitsüülhape |
B01AC85 |
VIATRIS HEALTHCARE Limited |
|
Ikervis - silmatilgad, emulsioon (1mg 1ml)
|
tsüklosporiin |
S01XA18 |
Santen Oy |
|
Ilaris
|
kanakinumab |
L04AC08 |
Novartis Europharm Ltd |
|
Illument
|
– |
– |
– |
|
Ilumetri
|
tildrakizumab |
L04AC17 |
Almirall S.A. |
|
Ilumira - radiofarmatseutilise prekursori lahus (37gbq 1ml)
|
luteetsium(177Lu)kloriid |
V10XX84 |
SHINE Europe B.V. |
|
Imaavy - infusioonilahuse kontsentraat (185mg 1ml)
|
nipokalimab |
L04AL03 |
Janssen - Cilag International |
|
Imakrebin - tabl 100mg n10; n20; n30; n60; n90; n120; n180
|
Imatinib |
L01XE01 |
Alvogen IPCo S.ar.l. |
|
Imakrebin - tabl 400mg n10; n20; n30; n60; n90; n120; n180
|
Imatinib |
L01XE01 |
Alvogen IPCo S.ar.l. |
|
Imalgene 100 mgml - süstelahus (100mg 1ml)
|
ketamiin |
QN01AX03 |
Merial |
|
Imaplix
|
apremilast |
L04AA32 |
Norameda UAB |
|
Imatinib Accord
|
imatiniib |
L01XE01 |
Accord Healthcare S.L.U. |
|
Imatinib Actavis
|
imatinib |
L01XE01 |
Actavis Group PTC ehf |
|
Imatinib actavis group - tabl 100mg n30; n60; n90; n120
|
Imatinib |
L01XE01 |
Actavis Group PTC ehf |
|
Imatinib actavis group - tabl 200mg n30; n60; n90; n120
|
Imatinib |
L01XE01 |
Actavis Group PTC ehf |
|
Imatinib actavis group - tabl 300mg n30; n60; n90; n120
|
Imatinib |
L01XE01 |
Actavis Group PTC ehf |
|
Imatinib actavis group - tabl 400mg n30; n60; n90; n120
|
Imatinib |
L01XE01 |
Actavis Group PTC ehf |
|
Imatinib amomed - õhukese polümeerikattega tablett (100mg)
|
imatiniib |
L01XE01 |
Amomed Pharma GmbH |
|
Imatinib amomed - õhukese polümeerikattega tablett (400mg)
|
imatiniib |
L01XE01 |
Amomed Pharma GmbH |
|
Imatinib bioorganics 100mg - õhukese polümeerikattega tablett (100mg)
|
imatiniib |
L01XE01 |
BioOrganics BV |
|
Imatinib bioorganics 400mg - õhukese polümeerikattega tablett (400mg)
|
imatiniib |
L01XE01 |
BioOrganics BV |
|
Imatinib fresenius kabi - õhukese polümeerikattega tablett (100mg)
|
imatiniib |
L01XE01 |
Fresenius Kabi Deutschland GmbH |
|
Imatinib fresenius kabi - õhukese polümeerikattega tablett (400mg)
|
imatiniib |
L01XE01 |
Fresenius Kabi Deutschland GmbH |
|
Imatinib grindeks - kõvakapsel (100mg)
|
imatiniib |
L01XE01 |
Grindeks AS |
|
Imatinib krka - õhukese polümeerikattega tablett (100mg)
|
imatiniib |
L01XE01 |
KRKA d.d., Novo mesto |
|
Imatinib krka - õhukese polümeerikattega tablett (400mg)
|
imatiniib |
L01XE01 |
KRKA d.d., Novo mesto |
|
Imatinib laboratorios liconsa - õhukese polümeerikattega tablett (300mg)
|
imatiniib |
L01XE01 |
LABORATORIOS LICONSA, S.A. |
|
Imatinib ranbaxy 100 mg - tabl 100mg n30; n60; n90; n100; n120
|
Imatinib |
L01XE01 |
Ranbaxy (UK) Ltd. |
|
Imatinib ranbaxy 400 mg - tabl 400mg n30; n60; n90; n100; n120
|
Imatinib |
L01XE01 |
Ranbaxy (UK) Ltd. |
|
Imatinib sandoz - õhukese polümeerikattega tablett (100mg)
|
imatiniib |
L01XE01 |
Sandoz Pharmaceuticals d.d. |
|
Imatinib sandoz - õhukese polümeerikattega tablett (400mg)
|
imatiniib |
L01XE01 |
Sandoz Pharmaceuticals d.d. |
|
Imatinib sanoswiss 100mg - õhukese polümeerikattega tablett (100mg)
|
imatiniib |
L01XE01 |
UAB SanoSwiss |
|
Imatinib sanoswiss 400mg - õhukese polümeerikattega tablett (400mg)
|
imatiniib |
L01XE01 |
UAB SanoSwiss |
|
Imatinib synthon 100mg - õhukese polümeerikattega tablett (100mg)
|
imatiniib |
L01XE01 |
Synthon BV |
|
Imatinib synthon 400mg - õhukese polümeerikattega tablett (400mg)
|
imatiniib |
L01XE01 |
Synthon BV |
|
Imatinib Teva
|
imatiniib |
L01XE01 |
Teva Pharma B.V. |
|
Imatinib teva pharma 100mg - tabl 100mg n20; n60; n120; n180
|
Imatinib |
L01XE01 |
Teva Pharma B.V. |
|
Imatinib teva pharma 100mg - tabl 100mg n20; n60; n120; n180; n100; n500
|
Imatinib |
L01XE01 |
Teva Pharma B.V. |
|
Imatinib teva pharma 400mg - tabl 400mg n30; n90
|
Imatinib |
L01XE01 |
Teva Pharma B.V. |
|
Imatinib teva pharma 400mg - tabl 400mg n30; n90; n100; n500
|
Imatinib |
L01XE01 |
Teva Pharma B.V. |
|
Imatinib zentiva 100 mg - õhukese polümeerikattega tablett (100mg)
|
imatiniib |
L01XE01 |
Zentiva k.s. |
|
Imavec 100 mg - tabl 100mg n20; n60; n120; n180
|
Imatinib |
L01XE01 |
Helm AG |
|
Imavec 400 mg - tabl 400mg n10; n30; n90
|
Imatinib |
L01XE01 |
Helm AG |
|
Imaverol - nahalahuse kontsentraat (100mg 1ml)
|
enilkonasool |
QD01AC90 |
Eli Lilly Regional Operations GmbH |
|
Imazol - nahapasta (10mg 1g)
|
klotrimasool |
D01AC01 |
Laboratoires Bailleul S.A. |
|
Imazol plus - kreem (10mg +2,5mg 1g)
|
klotrimasool +heksamidiin |
D01AC81 |
Laboratoires Bailleul S.A. |
|
Imbruvica
|
ibrutiniib |
L01EL01 |
Janssen - Cilag International |
|
Imcivree - süstelahus (10mg 1ml)
|
setmelanotiid |
A08AA12 |
Rhythm Pharmaceuticals Netherlands B.V. |
|
Imdur - toimeainet prolongeeritult vabastav tablett (60mg)
|
isosorbiitmononitraat |
C01DA14 |
TopRidge Pharma (Ireland) Limited |
|
Imex - salv 30mg / g 20g
|
Tetracycline |
D06AA04 |
Merz Pharmaceuticals GmbH |
|
Imfinzi - infusioonilahuse kontsentraat (50mg 1ml)
|
durvalumab |
L01FF03 |
AstraZeneca AB |
|
Imigran
|
– |
– |
– |
|
Imigran fdt - õhukese polümeerikattega tablett (100mg)
|
sumatriptaan |
N02CC01 |
GlaxoSmithKline Trading Services Limited |
|
Imigran fdt - õhukese polümeerikattega tablett (50mg)
|
sumatriptaan |
N02CC01 |
GlaxoSmithKline Trading Services Limited |
|
Imipenemcilastatin actavis - infusioonilahuse pulber (500mg +500mg)
|
imipeneem +tsilastatiin |
J01DH51 |
Actavis Group PTC ehf |
|
Imipenemcilastatin hospira - infusioonilahuse pulber (500mg +500mg)
|
imipeneem +tsilastatiin |
J01DH51 |
Hospira UK Limited |
|
Imipenemcilastatin kabi
|
imipeneem +tsilastatiin |
J01DH51 |
Fresenius Kabi Polska Sp. z o.o. |
|
Imipenemcilastatin venus pharma - infusioonilahuse pulber (500mg +500mg)
|
imipeneem +tsilastatiin |
J01DH51 |
Venus Pharma GmbH |
|
Imjudo - infusioonilahuse kontsentraat (20mg 1ml)
|
tremelimumab |
L01FX20 |
Astrazeneca AB |
|
Imlygic
|
talimogeenlaherparepvek |
L01XL02 |
Amgen Europe B.V. |
|
Immucyst - inj subst 81mg n1
|
BCG bacteria |
L03AX03 |
Sanofi Pasteur S.A. |
|
Immunate 1000 rü750 rü - süstelahuse pulber ja lahusti (750rü +1000rü)
|
von Willebrandi faktor +VIII hüübimisfaktor |
B02BD06 |
Baxalta Innovations GmbH |
|
Immunate 250 rü190 rü - süstelahuse pulber ja lahusti (190rü +250rü)
|
von Willebrandi faktor +VIII hüübimisfaktor |
B02BD06 |
Baxalta Innovations GmbH |
|
Immunate 500 rü375 rü - süstelahuse pulber ja lahusti (375rü +500rü)
|
von Willebrandi faktor +VIII hüübimisfaktor |
B02BD06 |
Baxalta Innovations GmbH |
|
Immunate baxter 1000
|
– |
– |
– |
|
Immunate baxter 250
|
– |
– |
– |
|
Immunate baxter 500
|
– |
– |
– |
|
Immunine - inj / inf lahuse pulber ja lahusti 1200rü n1
|
Human coagulation factor IX |
B02BD04 |
Baxalta Innovations GmbH |
|
Immunine - inj / inf lahuse pulber ja lahusti 600rü n1
|
Human coagulation factor IX |
B02BD04 |
Baxalta Innovations GmbH |
|
Immunine - süste-/infusioonilahuse pulber ja lahusti (1200rü)
|
IX hüübimisfaktor |
B02BD04 |
Baxalta Innovations GmbH |
|
Immunine - süste-/infusioonilahuse pulber ja lahusti (600rü)
|
IX hüübimisfaktor |
B02BD04 |
Baxalta Innovations GmbH |
|
Immunine baxter 200 iu
|
– |
– |
– |
|
Immunoprin
|
– |
– |
– |
|
Immunoprin 100 mg - õhukese polümeerikattega tablett (100mg)
|
asatiopriin |
L04AX01 |
Sandoz Pharmaceuticals d.d. |
|
Immunoprin 75 mg - õhukese polümeerikattega tablett (75mg)
|
asatiopriin |
L04AX01 |
Sandoz Pharmaceuticals d.d. |
|
Imnovid
|
pomalidomiid |
L04AX06 |
Bristol-Myers Squibb Pharma EEIG |
|
Imnovid (previously Pomalidomide Celgene)
|
pomalidomide |
Celgene Europe Ltd |
Authorised |
|
Imodium
|
– |
– |
– |
|
Imodium - kõvakapsel (2mg)
|
loperamiid |
A07DA03 |
McNeil Products Limited |
|
Imodium instant - suus dispergeeruv tablett (2mg)
|
loperamiid |
A07DA03 |
McNeil Products Limited |
|
Imogam rabies, pasteurized - süstelahus (150rü 1ml)
|
marutõve immunoglobuliin |
J06BB05 |
Sanofi Pasteur |
|
Imovane - õhukese polümeerikattega tablett (7,5mg)
|
zopikloon |
N05CF01 |
Sanofi-Aventis Estonia OÜ |
|
Imovax d.t. adult - süstesuspensioon (20rü +2rü 0.5ml)
|
teetanuse toksoid +difteeria toksoid |
J07AM51 |
Sanofi Pasteur |
|
Imovax d.t. adult - süstesuspensioon süstlis (20rü +2rü 0.5ml)
|
teetanuse toksoid +difteeria toksoid |
J07AM51 |
Sanofi Winthrop Industrie |
|
Imovax polio - inj susp 0,5ml 1annus n1
|
Poliomyelitis, trivalent, inactivated, whole virus |
J07BF03 |
Sanofi Pasteur S.A. |
|
Imovax polio - süstesuspensioon (1annus 0.5ml)
|
poliomüeliidi koguviirus, trivalentne, inaktiveeritud |
J07BF03 |
Sanofi Winthrop Industrie |
|
Imovax polio - süstesuspensioon (1annust 0.5ml)
|
poliomüeliidi koguviirus, trivalentne, inaktiveeritu |
J07BF03 |
Sanofi Pasteur |
|
Implicor 50mg5mg - õhukese polümeerikattega tablett (50mg +5mg)
|
metoprolool +ivabradiin |
C07FX05 |
Les Laboratories Servier |
|
Implicor 50mg7.5mg - õhukese polümeerikattega tablett (50mg +7,5mg)
|
metoprolool +ivabradiin |
C07FX05 |
Les Laboratories Servier |
|
Imprida HCT
|
amlodipine / valsartan / hydrochlorothiazide |
C09DB03 |
Novartis Europharm Ltd. |
|
Imraldi
|
adalimumab |
L04AB04 |
Samsung Bioepis NL B.V. |
|
Imuldosa
|
ustekinumab |
L04AC05 |
Accord Healthcare S.L.U. |
|
Imuran - õhukese polümeerikattega tablett (50mg)
|
asatiopriin |
L04AX01 |
Lex Ano UAB |
|
Imvanex
|
rõuge-/ahvirõugevaktsiin |
J07BX01 |
Bavarian Nordic A/S |
|
Imvel - tabl 50mg n10; n20; n30; n50; n60; n90
|
Cyproterone |
G03HA01 |
ELVIM LTD |
|
Inaqovi - õhukese polümeerikattega tablett (35mg +100mg)
|
detsitabiin +tsedasuridiin |
L01BC84 |
Otsuka Pharmaceutical Netherlands B.V. |
|
Inbrija - inhalatsioonipulber kõvakapslis (33mg)
|
levodopa |
N04BA01 |
Merz Therapeutics GmbH |
|
Incellipan - süstesuspensioon süstlis (1annus 0.5ml)
|
gripiviirus, inaktiveeritud, tükeldatud viirus või pinnaantigeen |
J07BB02 |
Seqirus Netherlands B.V. |
|
Incivo
|
telaprevir |
J05AE |
Janssen-Cilag International N.V. |
|
Increlex
|
mekasermiin |
H01AC03 |
Ipsen Pharma |
|
Incresync
|
pioglitasoon +alogliptiin |
A10BD09 |
Takeda Pharma A/S |
|
Incruse
|
umeclidinium bromide |
R03BB07 |
Glaxo Group Ltd |
|
Incruse ellipta - annustatud inhalatsioonipulber (55mcg 1mõõtannus)
|
umeklidiinium |
R03BB07 |
GlaxoSmithKline (Ireland) Limited |
|
Indamax - toimeainet prolongeeritult vabastav tablett (1,5mg)
|
indapamiid |
C03BA11 |
Teva Pharma B.V. |
|
Indapamide actavis
|
– |
– |
– |
|
Indapamide sr servier - toimeainet prolongeeritult vabastav tablett (1,5mg)
|
indapamiid |
C03BA11 |
Les Laboratories Servier |
|
Indomet- ratiopharm 50mg - kõvakapsel (50mg)
|
indometatsiin |
M01AB01 |
ratiopharm GmbH |
|
Indomet-ratiopharm Gel
|
– |
– |
– |
|
InductOs
|
dibotermin alfa |
M05BC01 |
Medtronic BioPharma B.V. |
|
Inegy
|
– |
– |
– |
|
Infanrix Hexa
|
diphtheria toxoid / tetanus toxoid / Bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin) / hepatitis B surface antigen / poliovirus (inactivated) (type 1 (Mahoney strain), type 2 (MEF-1 strain), type 3 (Saukett strain)) / Haemophilus influenzae type b polysaccharide |
J07CA09 |
GlaxoSmithKline Biologicals S.A. |
|
Infanrix Penta
|
diphtheria toxoid / tetanus toxoid / Bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin) / hepatitis-B surface antigen / poliovirus (inactivated) (type 1 (Mahoney strain), type 2 (MEF-1 strain), type 3 (Saukett strain)) |
J07CA12 |
GlaxoSmithKline Biologicals S.A. |
|
Infanrix polio - inj susp süstlis 0,5 ml n1; n20; n10
|
Diphtheria toxoid Pertussis, purified antigen Tetanus toxoid Poliomyelitis, trivalent, inactivated, whole virus |
J07CA02 |
GlaxoSmithKline Biologicals s.a. |
|
Infanrix polio - süstesuspensioon süstlis (1annus +1annus +1annus +1annus 0.5ml)
|
difteeria toksoid +läkaköha tekitaja, puhastatud antigeen +teetanuse toksoid +poliomüeliidi koguviirus, trivalentne, inaktiveeritud |
J07CA02 |
Glaxosmithkline Biologicals |
|
Infanrix polio - süstesuspensioon süstlis (30rü +25mcg +40rü +0)
|
difteeria toksoid +läkaköha tekitaja, puhastatud antigeen +teetanuse toksoid +poliomüeliidi koguviirus, trivalentne, inaktiveeritu |
J07CA02 |
GlaxoSmithKline Biologicals s.a. |
|
Infanrix-ipv hib - inj susp pulber ja susp 30rü 25mcg >40rü n1 inj subst 10 mcg 0,5ml n1
|
Diphtheria toxoid Tetanus toxoid Pertussis, purified antigen Poliomyelitis, trivalent, inactivated, whole virus Haemophilus influenzae B, purified antigen conjugated |
J07CA06 |
GlaxoSmithKline Biologicals s.a. |
|
Infanrix-ipv+hib - süstesuspensiooni pulber ja suspensioon (30rü +40rü +25mcg +0 +10mcg 0.5ml)
|
difteeria toksoid +teetanuse toksoid +läkaköha tekitaja, puhastatud antigeen +poliomüeliidi koguviirus, trivalentne, inaktiveeritu +haemophilus influenzae B, konjugeeritud, puhastatud antigeen |
J07CA06 |
GlaxoSmithKline Biologicals s.a. |
|
Inflectra
|
infliximab |
L04AB02 |
Hospira UK Limited |
|
Influvac - inj susp 0,5ml täidetud süstal n1; n10
|
Influenza, inactivated, split virus or surface antigen |
J07BB02 |
BGP Products B.V. |
|
Influvac - süstesuspensioon (1annust 0.5ml)
|
gripiviirus, inaktiveeritud, tükeldatud viirus või pinnaantigeen |
J07BB02 |
BGP Products SIA |
|
Influvac - süstesuspensioon süstlis (1annus 0.5ml)
|
gripiviirus, inaktiveeritud, tükeldatud viirus või pinnaantigeen |
J07BB02 |
VIATRIS HEALTHCARE Limited |
|
Influvac tetra - süstesuspensioon süstlis (1annus 0.5ml)
|
gripiviirus, inaktiveeritud, tükeldatud viirus või pinnaantigeen |
J07BB02 |
VIATRIS HEALTHCARE Limited |
|
Infragil pekana - pillid
|
homöopaatilised preparaadid |
V03AX82 |
PEKANA Naturheilmittel GmbH |
|
Infutraze - infusioonilahuse kontsentraat
|
elektrolüüdid |
B05XA80 |
Fresenius Kabi AB |
|
Ingelvac mycoflex - süstesuspensioon (1annust)
|
mükoplasma |
QI09AB13 |
Boehringer Ingelheim Vetmedica GmbH |
|
Ingelvac prrsflex eu - süstesuspensiooni lüofilisaat ja lahusti
|
sigade reproduktiiv-respiratoorse sündroomi viirus |
QI09AD03 |
Boehringer Ingelheim Vetmedica GmbH |
|
Inhafort - inhalatsioonipulber kõvakapslis (12mcg)
|
formoterool |
R03AC13 |
PharmaSwiss Ceska republika s.r.o |
|
Inhixa
|
naatriumenoksapariin |
B01AB05 |
Techdow Pharma Netherlands B.V. |
|
Inlyta
|
axitinib |
L01XE17 |
Pfizer Ltd.
|
|
INOmax
|
nitric oxide |
R07AX01 |
Linde Healthcare AB |
|
Inovelon
|
rufinamiid |
N03AF03 |
Eisai Ltd. |
|
Inrebic - kõvakapsel (100mg)
|
fedratiniib |
L01EJ02 |
Bristol-Myers Squibb Pharma EEIG |
|
Insistor - süstelahus (8,9mg 1ml)
|
metadoon |
QN02AC90 |
Richter Pharma AG |
|
Inspra - õhukese polümeerikattega tablett (25mg)
|
eplerenoon |
C03DA04 |
Pfizer Europe MA EEIG |
|
Inspra - õhukese polümeerikattega tablett (50mg)
|
eplerenoon |
C03DA04 |
Pfizer Europe MA EEIG |
|
Instanyl
|
fentanyl citrate |
N02AB03 |
Takeda Pharma A/S |
|
Instillido - geel (20mg 1ml)
|
lidokaiin |
N01BB02 |
Farco-Pharma GmbH |
|
Insulatard
|
keskmise toimeajaga humaaninsuliin |
A10AC01 |
Novo Nordisk A/S |
|
Insulin aspart sanofi
|
aspart-insuliin |
A10AB05 |
Sanofi Winthrop Industrie |
|
Insulin Human Winthrop
|
insulin human |
A10ABCD01 |
Sanofi-aventis Deutschland GmbH |
|
Insulin lispro sanofi
|
lispro-insuliin |
A10AB04 |
Sanofi Winthrop Industrie |
|
Insuman
|
insulin human |
A10ABCD01 |
sanofi-aventis Deutschland GmbH |
|
Intanza
|
A/California/7/2009 (H1N1)pdm09-derived strainA/Victoria/361/2011 (H3N2)-like strainB/Massachusetts/02/2012 |
J07BB02 |
Sanofi Pasteur MSD, SNC |
|
Integrilin
|
eptifibatiid |
B01AC16 |
GlaxoSmithKline (Ireland) Limited |
|
Intelence
|
etravirine |
J05AG04 |
Janssen-Cilag International NV |
|
Interflox oral - lahus joogivees manustamiseks (100mg 1ml)
|
enrofloksatsiin |
QJ01MA90 |
Interchemie Werken De Adelaar Eesti AS |
|
Interflox-100 - süstelahus (100mg 1ml)
|
enrofloksatsiin |
QJ01MA90 |
Interchemie Werken De Adelaar Eesti AS |
|
Intermec - süstelahus (10mg 1ml)
|
ivermektiin |
QP54AA01 |
Interchemie Werken De Adelaar Eesti AS |
|
Intermec plus - süstelahus (10mg +100mg 1ml)
|
ivermektiin +klorsuloon |
QP54AA81 |
Interchemie Werken De Adelaar Eesti AS |
|
Intra hoof-fit gel - geel (40mg +40mg 1g)
|
vask +tsink |
QD03AX80 |
Intracare BV |
|
Intracox oral - lahus joogivees manustamiseks (25mg 1ml)
|
toltrasuriil |
QP51AJ01 |
Interchemie Werken De Adelaar Eesti AS |
|
Intralipid - infusiooniemulsioon (20%)
|
rasvemulsioonid |
B05BA02 |
FRESENIUS KABI AB |
|
Intrarosa - vaginaalsuposiit (6,5mg)
|
prasteroon |
G03XX01 |
Endoceutics |
|
Intraseal - intramammaarsuspensioon (2,6g 4g)
|
vismutsubnitraat |
QG52XX80 |
Norbrook Laboratories Limited |
|
Intrinsa
|
testosterone |
G03BA03 |
Warner Chilcott UK Ltd. |
|
IntronA
|
interferon alfa-2b |
L03AB05 |
Merck Sharp & Dohme Limited |
|
Intuniv
|
guanfatsiin |
C02AC02 |
Takeda Pharmaceuticals International AG Ireland Branch |
|
Invanz
|
ertapenem sodium |
J01DH03 |
Merck Sharp & Dohme Ltd. |
|
Invega
|
paliperidoon |
N05AX13 |
Janssen-Cilag International NV |
|
Invirase
|
saquinavir |
J05AE01 |
Roche Registration Ltd. |
|
Invokana
|
kanagliflosiin |
A10BK02 |
Janssen - Cilag International |
|
Ioa
|
nomegestrol acetate / estradiol |
G03AA14 |
N.V. Organon |
|
Iodine valentis - nahalahus (50mg 1ml)
|
jood |
D08AG03 |
Valentis UAB |
|
Iodine valentis - nahalahus 50mg / ml 10ml n1; 20ml n1
|
Iodine |
D08AG03 |
UAB "Valentis" |
|
Iodopol - kõvakapsel
|
naatriumjodiid (131I) |
V10XA01 |
Narodowe Centrum Badan Jadrowych |
|
Iohexol hovione - inj lahus 755mg / 1ml 50ml n10; 100ml n10
|
Iohexol |
V08AB02 |
Hovione FarmaCiencia S.A |
|
Iohexol icg farma
|
joheksool |
V08AB02 |
Icg Farma UAB |
|
Iohexol imax - süstelahus (647mg 1ml)
|
joheksool |
V08AB02 |
IMAX Diagnostic Imaging Limited |
|
Iohexol imax - süstelahus (755mg 1ml)
|
joheksool |
V08AB02 |
IMAX Diagnostic Imaging Limited |
|
Iopamigita 300 - süste-/infusioonilahus (612,4mg 1ml)
|
jopamidool |
V08AB04 |
Agfa HealthCare Imaging Agents GmbH |
|
Iopamigita 370 - süste-/infusioonilahus (755,2mg 1ml)
|
jopamidool |
V08AB04 |
Agfa HealthCare Imaging Agents GmbH |
|
Iopamiro
|
jopamidool |
V08AB04 |
Bracco Imaging S.p.A. |
|
Iopamiro 300 - inj 612mg / ml amp 10ml n5; pudel: 30ml n1; 50ml n1; 100ml n1; 200ml n1; 500ml n1
|
Iopamidol |
V08AB04 |
Bracco Imaging S.p.A. |
|
Iopamiro 300 - süstelahus (612mg 1ml)
|
jopamidool |
V08AB04 |
Bracco Imaging S.p.A. |
|
Iopamiro 370 - inj 755mg / ml 30ml n1; 50ml n1; 100ml n1; 200ml n1; 500ml n1
|
Iopamidol |
V08AB04 |
Bracco Imaging S.p.A. |
|
Iopamiro 370 - süstelahus (755mg 1ml)
|
jopamidool |
V08AB04 |
Bracco Imaging S.p.A. |
|
Ipraalox - gastroresistentne tablett (20mg)
|
pantoprasool |
A02BC02 |
sanofi-aventis Estonia OÜ |
|
Ipratropium bromide newline pharma - inhalatsiooniaerosool, lahus (20mcg 1pihustus)
|
ipratroopiumbromiid |
R03BB01 |
Newline Pharma, S.L. |
|
Ipreziv
|
azilsartan medoxomil |
C09CA09 |
Takeda Pharma A/S |
|
Iqirvo - õhukese polümeerikattega tablett (80mg)
|
elafibranoor |
A05AX06 |
Ipsen Pharma |
|
Irbesartan / Hydrochlorothiazide Teva
|
irbesartaan +hüdroklorotiasiid |
C09DA83 |
Teva B.V. |
|
Irbesartan accord 150mg
|
– |
– |
– |
|
Irbesartan accord 300mg
|
– |
– |
– |
|
Irbesartan accord 75mg
|
– |
– |
– |
|
Irbesartan actavis
|
– |
– |
– |
|
Irbesartan hydrochlorothiazide gentian generics - tabl 150mg 12,5mg n14; n28; n30; n56; n60; n98; n100; n250; n500
|
Irbesartan Hydrochlorothiazide |
C09DA04 |
Gentian Generics Limited |
|
Irbesartan hydrochlorothiazide gentian generics - tabl 300mg 12,5mg n14; n28; n30; n56; n60; n98; n100; n250; n500
|
Irbesartan Hydrochlorothiazide |
C09DA04 |
Gentian Generics Limited |
|
Irbesartan hydrochlorothiazide gentian generics - tabl 300mg 25mg n14; n28; n30; n56; n60; n98; n100; n250; n500
|
Irbesartan Hydrochlorothiazide |
C09DA04 |
Gentian Generics Limited |
|
Irbesartan Hydrochlorothiazide Nucleus
|
– |
– |
– |
|
Irbesartan hydrochlorothiazide sigillata - tabl 150mg 12,5mg n28
|
Irbesartan Hydrochlorothiazide |
C09DA04 |
Sigillata Ltd |
|
Irbesartan hydrochlorothiazide sigillata - tabl 300mg 12,5mg n28
|
Irbesartan Hydrochlorothiazide |
C09DA04 |
Sigillata Ltd |
|
Irbesartan hydrochlorothiazide sigillata - tabl 300mg 25mg n28
|
Irbesartan Hydrochlorothiazide |
C09DA04 |
Sigillata Ltd |
|
Irbesartan hydrochlorothiazide zentiva
|
irbesartaan +hüdroklorotiasiid |
C09DA83 |
Zentiva k.s. |
|
Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop)
|
irbesartan |
C09CA04 |
Sanofi-aventis groupe
|
|
Irbesartan liconsa 150 mg - tablett (150mg)
|
irbesartaan |
C09CA04 |
LABORATORIOS LICONSA, S.A. |
|
Irbesartan liconsa 300 mg - tablett (300mg)
|
irbesartaan |
C09CA04 |
LABORATORIOS LICONSA, S.A. |
|
Irbesartan liconsa 75 mg - tablett (75mg)
|
irbesartaan |
C09CA04 |
LABORATORIOS LICONSA, S.A. |
|
Irbesartan medis 150 mg - õhukese polümeerikattega tablett (150mg)
|
irbesartaan |
C09CA04 |
Medis ehf. |
|
Irbesartan medis 300 mg - õhukese polümeerikattega tablett (300mg)
|
irbesartaan |
C09CA04 |
Medis ehf. |
|
Irbesartan medis 75 mg - õhukese polümeerikattega tablett (75mg)
|
irbesartaan |
C09CA04 |
Medis ehf. |
|
Irbesartan medis 75 mg - tabl 75mg n14; n28; n30; n56; n60; n90; n84; n98; n250
|
Irbesartan |
C09CA04 |
Medis ehf. |
|
Irbesartan miklich
|
– |
– |
– |
|
Irbesartan ranbaxy 150 mg
|
– |
– |
– |
|
Irbesartan ranbaxy 300 mg
|
– |
– |
– |
|
Irbesartan Teva
|
irbesartan |
C09CA04 |
Teva Pharma B.V. |
|
Irbesartan zentiva
|
irbesartaan |
C09CA04 |
Zentiva k.s. |
|
Irbesartan Zentiva (previously Irbesartan Winthrop)
|
– |
– |
– |
|
Irbesartan/Hydrochlorothiazide Teva
|
irbesartan / hydrochlorothiazide |
C09DA04 |
Teva Pharma B.V.
|
|
Irbesartanhydrochlorothiazide actavis - õhukese polümeerikattega tablett (150mg +12,5mg)
|
irbesartaan +hüdroklorotiasiid |
C09DA04 |
Actavis Group PTC ehf |
|
Irbesartanhydrochlorothiazide actavis - õhukese polümeerikattega tablett (300mg +12,5mg)
|
irbesartaan +hüdroklorotiasiid |
C09DA04 |
Actavis Group PTC ehf |
|
Irbesartanhydrochlorothiazide actavis - õhukese polümeerikattega tablett (300mg +25mg)
|
irbesartaan +hüdroklorotiasiid |
C09DA04 |
Actavis Group PTC ehf |
|
Irdeonhact
|
– |
– |
– |
|
Iressa
|
gefitiniib |
L01XE02 |
AstraZeneca AB |
|
Irexime - geel (10mg +50mg 1g)
|
klindamütsiin +bensoüülperoksiid |
D10AF81 |
Orifarm Healthcare A/S |
|
Irfen quiktabs 200 mg
|
– |
– |
– |
|
Irinotecan accord
|
– |
– |
– |
|
Irinotecan accord - infusioonilahuse kontsentraat (20mg 1ml)
|
irinotekaan |
L01XX19 |
Accord Healthcare Limited |
|
Irinotecan actavis - infusioonilahuse kontsentraat (20mg 1ml)
|
irinotekaan |
L01XX19 |
Actavis Group PTC ehf |
|
Irinotecan Ebewe
|
– |
– |
– |
|
Irinotecan ebewe 20 mgml - infusioonilahuse kontsentraat (20mg 1ml)
|
irinotekaan |
L01XX19 |
Sandoz Pharmaceuticals d.d. |
|
Irinotecan fresenius - infusioonilahuse kontsentraat (20mg 1ml)
|
irinotekaan |
L01XX19 |
Fresenius Kabi Oncology Plc. |
|
Irinotecan Hospira
|
– |
– |
– |
|
Irinotecan hospira 20mgml infusioonilahuse kontsentraat - inf conc 20mg / ml 2ml n1; 5ml n1; 25ml n1
|
Irinotecan |
L01XX19 |
Hospira UK Limited |
|
Irinotecan hospira 20mgml infusioonilahuse kontsentraat - infusioonilahuse kontsentraat (20mg 1ml)
|
irinotekaan |
L01XX19 |
Hospira UK Limited |
|
Irinotecan Kabi
|
– |
– |
– |
|
Irinotecan kabi 20 mgml - infusioonilahuse kontsentraat (20mg 1ml)
|
irinotekaan |
L01XX19 |
Fresenius Kabi Polska Sp. z o.o. |
|
Irinotecan medac
|
– |
– |
– |
|
Irinotecan mylan - inf lahuse konts 20mg / 1ml 2ml n1; 5ml n1
|
Irinotecan |
L01XX19 |
Mylan S.A.S |
|
Irinotecan Orion
|
– |
– |
– |
|
Irinotecan pharmaswiss
|
– |
– |
– |
|
Irinotecan Polpharma
|
– |
– |
– |
|
Irinotecan seacross 20mgml - infusioonilahuse kontsentraat (20mg 1ml)
|
irinotekaan |
L01XX19 |
Seacross Pharmaceuticals Ltd |
|
Irinotecan teva - inf lahuse konts 20mg / 1ml 2ml n1; 2ml n5; 5ml n1; 5ml n5; 25ml n1; 25ml n5; 15ml n1; 15ml n5
|
Irinotecan |
L01XX19 |
Teva Pharma B.V. |
|
Irinotecan Vipharm
|
– |
– |
– |
|
Irprestan
|
– |
– |
– |
|
Irprezide - õhukese polümeerikattega tablett (150mg +12,5mg)
|
irbesartaan +hüdroklorotiasiid |
C09DA04 |
Actavis Group PTC ehf |
|
Irprezide - õhukese polümeerikattega tablett (300mg +12,5mg)
|
irbesartaan +hüdroklorotiasiid |
C09DA04 |
Actavis Group PTC ehf |
|
Irprezide - õhukese polümeerikattega tablett (300mg +25mg)
|
irbesartaan +hüdroklorotiasiid |
C09DA04 |
Actavis Group PTC ehf |
|
Irtucalan
|
– |
– |
– |
|
Isaderm - geel (1mg +5mg 1g)
|
beetametasoon +fusidiinhape |
QD07CC01 |
Dechra Veterinary Products A/S |
|
Iscover
|
klopidogreel |
B01AC04 |
Sanofi-aventis groupe |
|
Isdn-ratiopharm 20 mg - toimeainet prolongeeritult vabastav kõvakapsel (20mg)
|
isosorbiitdinitraat |
C01DA08 |
ratiopharm GmbH |
|
Isdn-ratiopharm 40 mg - toimeainet prolongeeritult vabastav kõvakapsel (40mg)
|
isosorbiitdinitraat |
C01DA08 |
ratiopharm GmbH |
|
Isdn-ratiopharm 5 mg - tablett (5mg)
|
isosorbiitdinitraat |
C01DA08 |
ratiopharm GmbH |
|
Isentress
|
raltegravir |
J05AX08 |
Merck Sharp & Dohme Ltd. |
|
Isocare - inhalatsiooniaur, vedelik (1000mg 1g)
|
isofluraan |
QN01AB06 |
Animalcare Ltd |
|
Isoket 20
|
– |
– |
– |
|
Isoket 40
|
– |
– |
– |
|
Isomonit 20 mg
|
– |
– |
– |
|
Isomonit 40 mg
|
– |
– |
– |
|
Isomonit 60 mg - toimeainet prolongeeritult vabastav tablett (60mg)
|
isosorbiitmononitraat |
C01DA14 |
HEXAL AG |
|
Isoptin retard - toimeainet prolongeeritult vabastav tablett (240mg)
|
verapamiil |
C08DA01 |
Mylan Healthcare GmbH |
|
Isoptin retard 120 mg - toimeainet prolongeeritult vabastav tablett (120mg)
|
verapamiil |
C08DA01 |
Viatris SIA |
|
Isosor 20mg
|
– |
– |
– |
|
Isosorbide mononitrate vitabalans - tablett (20mg)
|
isosorbiitmononitraat |
C01DA14 |
VITABALANS OY |
|
Isotiorga - pehmekapsel (20mg)
|
isotretinoiin |
D10BA01 |
Laboratoires Bailleul S.A. |
|
Isotretinoin sandoz
|
isotretinoiin |
D10BA01 |
Sandoz Pharmaceuticals d.d. |
|
Isotretinoin sandoz 10 mg
|
– |
– |
– |
|
Isotretinoin sandoz 20 mg
|
– |
– |
– |
|
Isturisa
|
osilodrostaat |
H02CA02 |
Recordati Rare Diseases |
|
Itires pekana - pillid
|
homöopaatilised preparaadid |
V03AX82 |
PEKANA Naturheilmittel GmbH |
|
Itoprom - õhukese polümeerikattega tablett (50mg)
|
itopriid |
A03FA07 |
Pro.Med.Cs Praha a.s. |
|
Itovebi
|
inavolisiib |
L01EM06 |
Roche Registration GmbH |
|
Itraconazol actavis - kõvakapsel (100mg)
|
itrakonasool |
J02AC02 |
Teva B.V. |
|
Ituxredi
|
rituksimab |
L01FA01 |
Reddy Holding GmbH |
|
Itvisma - süstelahus (1annus)
|
onasemnogeenabeparvovek |
M09AX09 |
Novartis Europharm Limited |
|
Ivabradine accord
|
ivabradiin |
C01EB17 |
Accord Healthcare S.L.U. |
|
Ivabradine actavis - õhukese polümeerikattega tablett (5mg)
|
ivabradiin |
C01EB17 |
Actavis Group PTC ehf |
|
Ivabradine actavis - õhukese polümeerikattega tablett (7,5mg)
|
ivabradiin |
C01EB17 |
Actavis Group PTC ehf |
|
Ivabradine anpharm
|
ivabradiin |
C01EB17 |
Anpharm Przedsiebiorstwo Farmaceutyczne S.A. |
|
Ivabradine grindeks - õhukese polümeerikattega tablett (5mg)
|
ivabradiin |
C01EB17 |
AS Grindeks |
|
Ivabradine grindeks - õhukese polümeerikattega tablett (7,5mg)
|
ivabradiin |
C01EB17 |
AS Grindeks |
|
Ivabradine mylan - õhukese polümeerikattega tablett (5mg)
|
ivabradiin |
C01EB17 |
Mylan S.A.S |
|
Ivabradine mylan - õhukese polümeerikattega tablett (7,5mg)
|
ivabradiin |
C01EB17 |
Mylan S.A.S |
|
Ivabradine teva - õhukese polümeerikattega tablett (5mg)
|
ivabradiin |
C01EB17 |
Teva B.V. |
|
Ivabradine teva - õhukese polümeerikattega tablett (7,5mg)
|
ivabradiin |
C01EB17 |
Teva B.V. |
|
Ivabradine viatris
|
ivabradiin |
C01EB17 |
Viatris Limited |
|
Ivabradine zentiva
|
ivabradiin |
C01EB17 |
Zentiva k.s. |
|
Ivacaftor stada - õhukese polümeerikattega tablett (150mg)
|
ivakaftoor |
R07AX02 |
Stada Arzneimittel AG |
|
Ivacaftor teva - õhukese polümeerikattega tablett (150mg)
|
ivakaftoor |
R07AX02 |
Teva B.V. |
|
Ivemend
|
fosaprepitant |
A04AD81 |
Merck Sharp & Dohme Ltd |
|
Ivermectin orion - tablett (3mg)
|
ivermektiin |
P02CF01 |
Orion Corporation |
|
Iviverz - õhukese polümeerikattega tablett (300mg +600mg)
|
lamivudiin +abakaviir |
J05AR02 |
Actavis Group PTC ehf |
|
Ixbelor
|
edoksabaan |
B01AF03 |
Medochemie Limited |
|
Ixchiq - süstelahuse pulber ja lahusti (1annus 0.5ml)
|
Chikungunya viirus, elus, nõrgestatud |
J07BP01 |
Valneva Austria GmbH |
|
Ixel
|
– |
– |
– |
|
Ixhalanex
|
alprasolaam |
N05BA12 |
Grindeks AS |
|
Ixiaro
|
Japanese-encephalitis virus, inactivated (attenuated strain SA14-14-2 grown in vero cells) |
J07BA02 |
Valneva Austria GmbH |
|
Izamby - süstelahus süstlis (60mg 1ml)
|
denosumab |
M05BX04 |
Mabxience Research SL |
|
Izba
|
travoprost |
S01EE04 |
Novartis Europharm Limited |
